Pulmonx Corp - COM (LUNG) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2020 to Q4 2025

Type / Class
Equity / COM
Symbol
LUNG on Nasdaq
Shares outstanding
40,762,262
Price per share
$2.21
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
31,835,102
Total reported value
$51,571,421
% of total 13F portfolios
0%
Share change
-4,417,027
Value change
-$11,678,501
Number of holders
103
Price from insider filings
$2.21
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Pulmonx Corp - COM (LUNG) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PRIMECAP MANAGEMENT CO/CA/ 12% -10% $8,029,839 -$742,073 4,956,691 -8.5% PRIMECAP MANAGEMENT CO/CA/ 30 Sep 2025
MORGAN STANLEY 8.5% +12% $17,530,110 +$2,200,052 3,390,737 +14% Morgan Stanley 31 Mar 2025
BlackRock, Inc. 6.8% $13,933,140 2,694,998 BlackRock, Inc. 31 Mar 2025
FMR LLC 0.2% -104% $114,736 -$3,416,852 70,825 -97% FMR LLC 31 Oct 2025

As of 30 Sep 2025, 103 institutional investors reported holding 31,835,102 shares of Pulmonx Corp - COM (LUNG). This represents 78% of the company’s total 40,762,262 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Pulmonx Corp - COM (LUNG) together control 70% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
PRIMECAP MANAGEMENT CO/CA/ 12% 4,956,691 -4% 0.01% $8,029,840
MORGAN STANLEY 8.9% 3,620,676 +1.8% 0% $5,865,496
BlackRock, Inc. 6.6% 2,674,821 -0.59% 0% $4,333,210
VANGUARD GROUP INC 5.5% 2,242,187 -2.3% 0% $3,632,343
FMR LLC 5.3% 2,174,358 -49% 0% $3,522,461
SILVERCREST ASSET MANAGEMENT GROUP LLC 3.1% 1,264,233 +36% 0.01% $2,048,057
DEUTSCHE BANK AG\ 2.8% 1,125,861 0% 0% $1,823,895
GEODE CAPITAL MANAGEMENT, LLC 2.4% 978,762 +5.3% 0% $1,585,857
Kent Lake PR LLC 2.3% 926,157 0.77% $1,500,374
Vestal Point Capital, LP 2% 830,000 0.06% $1,344,600
STATE STREET CORP 1.9% 792,404 -0.22% 0% $1,283,694
D. E. Shaw & Co., Inc. 1.9% 789,249 +61% 0% $1,278,584
GSA CAPITAL PARTNERS LLP 1.9% 755,467 +78% 0.1% $1,224,000
BRAIDWELL LP 1.8% 752,541 0% 0.04% $1,219,116
Stonepine Capital Management, LLC 1.6% 670,000 +359% 0.88% $1,085,400
Parkman Healthcare Partners LLC 1.2% 500,662 -17% 0.09% $811,072
JPMORGAN CHASE & CO 1.2% 497,102 -16% 0% $805,306
BANK OF AMERICA CORP /DE/ 1.2% 479,023 -0.47% 0% $776,017
GOLDMAN SACHS GROUP INC 0.97% 394,890 +88% 0% $639,721
NORTHERN TRUST CORP 0.89% 362,371 +1.9% 0% $587,041
DIMENSIONAL FUND ADVISORS LP 0.85% 344,467 -24% 0% $558,151
BARCLAYS PLC 0.83% 339,682 +25% 0% $550,285
MILLENNIUM MANAGEMENT LLC 0.82% 335,849 -71% 0% $544,075
RENAISSANCE TECHNOLOGIES LLC 0.82% 332,810 +32% 0% $539,152
Jefferies Financial Group Inc. 0.7% 285,110 0% 0% $461,878

Institutional Holders of Pulmonx Corp - COM (LUNG) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 62,907 $139,029 +$38,886 $2.21 7
2025 Q3 31,835,102 $51,571,421 -$11,678,501 $1.62 103
2025 Q2 36,256,022 $93,898,311 -$4,596,833 $2.59 113
2025 Q1 36,156,132 $243,324,576 +$1,663,003 $6.73 114
2024 Q4 35,870,967 $243,565,337 +$1,640,704 $6.79 117
2024 Q3 35,563,337 $293,811,542 +$7,857,689 $8.29 112
2024 Q2 34,744,517 $220,280,080 -$2,027,570 $6.34 108
2024 Q1 34,672,382 $321,430,455 +$7,599,744 $9.27 117
2023 Q4 33,520,168 $427,381,569 +$18,995,295 $12.75 122
2023 Q3 33,253,122 $343,505,198 -$6,689,600 $10.33 113
2023 Q2 33,869,172 $443,992,925 -$9,642,079 $13.11 112
2023 Q1 34,707,575 $388,032,205 +$25,513,692 $11.18 101
2022 Q4 33,773,100 $284,706,913 -$83,075,336 $8.43 111
2022 Q3 34,912,391 $581,637,070 -$4,909,166 $16.66 100
2022 Q2 35,341,147 $520,187,047 -$7,902,826 $14.72 102
2022 Q1 34,711,340 $861,059,885 +$56,937,629 $24.81 105
2021 Q4 32,045,807 $1,027,712,027 +$25,949,573 $32.07 108
2021 Q3 31,600,475 $1,136,986,158 +$204,291,164 $35.98 118
2021 Q2 25,771,799 $1,136,970,052 +$216,275,676 $44.12 112
2021 Q1 20,788,776 $950,879,909 +$115,760,357 $45.74 107
2020 Q4 17,288,638 $1,179,671,046 +$1,018,686,046 $69.02 98